Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 June 2004, Vol. 103, No. 12, pp. 4554-4561.
Prepublished online as a Blood First Edition Paper on March 2, 2004; DOI 10.1182/blood-2003-07-2510.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-07-2510v1
103/12/4554    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shariat-Madar, Z.
Right arrow Articles by Schmaier, A. H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shariat-Madar, Z.
Right arrow Articles by Schmaier, A. H
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted July 28, 2003
Accepted February 19, 2004

Recombinant prolylcarboxypeptidase activates plasma prekallikrein

Zia Shariat-Madar, Fakhri Mahdi, and Alvin H Schmaier*

Internal Medicine and Pathology, University of Michigan, Ann Arbor, MI, USA

* Corresponding author; email: aschmaie{at}umich.edu.

The serine protease prolylcarboxypeptidase (PRCP) isolated from endothelial cells (HUVEC) is a plasma prekallikrein (PK) activator. PRCP cDNA was cloned in pMT/BIP/V5-HIS-C, transfected into S2 Schneider insect cells, and purified from serum-free media. Full-length recombinant PRCP (rPRCP) activates PK when bound to high molecular weight kininogen (HK). Recombinant PRCP is inhibited by leupeptin, angiotensin II, bradykinin, anti-PRCP, DFP, PMSF, Z-Pro-Pro-aldehyde-dimethyl acetate, but not by 1 mM EDTA, bradykinin 1-5, or angiotensin 1-7. Corn trypsin inhibitor binds to kallikrein to prevent rPRCP activation, but does not directly inhibit the active site of either enzyme. Unlike factor XIIa, ability of PRCP to activate PK is blocked by angiotensin II and not neutralizing antibody to factor XIIa. PRCP antigen is on HUVEC membranes on flow cytometry and laser scanning confocal microscopy. PRCP antigen does not co-localize with LAMP1 on non-permeabilized HUVEC, but partially co-localizes in permeabilized cells. PRCP co-localizes with all of the HK receptors, gC1qR, uPAR, and cytokeratin 1 antigen, on non-permeabilized HUVEC. PRCP activity and antigen expression on cultured HUVEC are blocked by a morpholino antisense oligonucleotide. These investigations indicate that rPRCP is functionally identical to isolated HUVEC PRCP and is a major HUVEC membrane-expressed PK activating enzyme in the intravascular compartment.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
J. M. Astern, W. F. Pendergraft III, R. J. Falk, J. C. Jennette, A. H. Schmaier, F. Mahdi, and G. A. Preston
Myeloperoxidase Interacts with Endothelial Cell-Surface Cytokeratin 1 and Modulates Bradykinin Production by the Plasma Kallikrein-Kinin System
Am. J. Pathol., July 1, 2007; 171(1): 349 - 360.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Z. Shariat-Madar, F. Mahdi, M. Warnock, J. W. Homeister, S. Srikanth, Y. Krijanovski, L. J. Murphey, A. A. Jaffa, and A. H. Schmaier
Bradykinin B2 receptor knockout mice are protected from thrombosis by increased nitric oxide and prostacyclin
Blood, July 1, 2006; 108(1): 192 - 199.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Shariat-Madar, E. Rahimy, F. Mahdi, and A. H. Schmaier
Overexpression of prolylcarboxypeptidase enhances plasma prekallikrein activation on Chinese hamster ovary cells
Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2697 - H2703.
[Abstract] [Full Text] [PDF]


Home page
ASH ANNUAL MEETING ABSTRACTSHome page
Z. Shariat-Madar, E. Rahimy, F. Mahdi, and A. H. Schmaier
Over-Expression of Prolylcarboxypeptidase Enhances Plasma Prekallikrein Activation on Chinese Hamster Ovary Cell Membranes.
Blood (ASH Annual Meeting Abstracts), November 16, 2005; 106(11): 3698 - 3698.
[Abstract]


Home page
J BiochemHome page
N. Kato, T. Okayama, H. Isawa, M. Yuda, Y. Chinzei, and S. Iwanaga
Contribution of the N-Terminal and C-Terminal Domains of Haemaphysalin to Inhibition of Activation of Plasma Kallikrein-Kinin System
J. Biochem., September 1, 2005; 138(3): 225 - 235.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2004 by American Society of Hematology         Online ISSN: 1528-0020